Summary & Overview
HCPCS C1760: Implantable Vascular Closure Device
HCPCS Level II code C1760 denotes an implantable or insertable vascular closure device used to achieve hemostasis after vascular access procedures. These devices are widely used in cardiovascular and interventional procedures to reduce time to hemostasis and facilitate patient recovery, affecting hospital and ambulatory surgical billing nationally. Understanding coding and coverage for C1760 is important for accurate device billing and inventory control.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of national payer coverage patterns, common billing modifiers, and the typical clinical contexts in which C1760 is reported. The publication summarises service settings, common use-cases in vascular and interventional procedures, and where to look for payer-specific policy language.
This summary provides: device description and clinical context; typical sites of service and procedural settings; payer landscape and coverage considerations; and references for further coding and policy review. Data not available in the input is noted where applicable. The goal is to inform coding professionals, billing staff, and health policy analysts about the role and billing context of HCPCS Level II code C1760 at a national level.
Billing Code Overview
HCPCS Level II code C1760 describes an implantable or insertable vascular closure device used to achieve hemostasis after vascular access procedures. The item is classified as a closure device, vascular (implantable/insertable).
Service type: Device implantation for vascular hemostasis.
Typical site of service: Hospital inpatient or outpatient vascular/interventional radiology suites and ambulatory surgical centers.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with symptomatic peripheral arterial disease and a chronic femoral artery puncture site undergoes implantation of a vascular closure device to achieve secure hemostasis after an endovascular diagnostic or therapeutic procedure. The device is implanted at the conclusion of an arterial access procedure performed in an interventional radiology or vascular surgery suite. Typical workflow: pre-procedure consent and assessment of access site and anticoagulation status; diagnostic angiography or peripheral intervention via transfemoral arterial access; heparin reversal or protamine consideration per protocol; deployment of the implantable vascular closure device under sterile conditions and image guidance as needed; post-deployment assessment of hemostasis, distal pulses, and access-site complications; recovery room monitoring and discharge instructions. Common clinical indications include prolonged manual compression risk, need for rapid ambulation after outpatient procedures, or anatomical considerations making manual compression difficult.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Standard reporting when no modifier applies to the service |
22 | Increased procedural services |